In Vivo Adaptive Resistance to Colistin in Escherichia coli Isolates

Clinical Infectious Diseases

Volumn 61, Issue 10, 2015, Pages 1628-1629

  Prim, Núria ^a   Rivera, Alba ^a   Español, Montserrat ^a   Mirelis, Beatriz ^a,b   Coll, Pere ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; COLISTIN; IMIPENEM; METRONIDAZOLE; POLYSORBATE 80; ANTIINFECTIVE AGENT;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD CULTURE; BLOODSTREAM INFECTION; BROTH DILUTION; CASE REPORT; EPSILOMETER TEST; ESCHERICHIA COLI; FEMALE; HUMAN; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEPSIS; URINARY TRACT INFECTION; URINE CULTURE; VERY ELDERLY; ADAPTATION; CHOLECYSTITIS; DRUG EFFECTS; ESCHERICHIA COLI INFECTION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ADAPTATION, PHYSIOLOGICAL; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHOLECYSTITIS; COLISTIN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; SEPSIS; URINARY TRACT INFECTIONS;

EID: 84947709935     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ645     Document Type: Letter

References (10)

1. Velkov T, Roberts KD, Nation RL, Thompson PE, Li J. Pharmacology of polymyxins: new insights into an 'old' class of antibiotics. Future Microbiol 2013; 8:711-24.
2. Gales AC, Jones RN, Sader HS. Contemporary activity of colistin and polymyxin B against a worldwide collection of gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09). J Antimicrob Chemother 2011; 66:2070-4.
3. Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol 2014; 5:643.
4. Wright MS, Suzuki Y, Jones MB, et al. Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance. Antimicrob Agents Chemother 2015; 59:536-43.
5. Fernández L, Gooderham WJ, Bains M, McPhee JB, Wiegand I, Hancock RE. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob Agents Chemother 2010; 54:3372-82.
6. Hindler JA, Humphries RM. Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant gramnegative bacilli. J Clin Microbiol 2013; 51: 1678-84.
7. Cannatelli A, Di Pilato V, Giani T, et al. In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with lowdosage colistin treatment. Antimicrob Agents Chemother 2014; 58:4399-403.
8. Groisman EA, Kayser J, Soncini FC. Regulation of polymyxin resistance and adaptation to low-Mg2+ environments. J Bacteriol 1997; 179:7040-5.
9. Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 2003; 55:27-55.
10. Hein-Kristensen L, Franzyk H, Holch A, Gram L. Adaptive evolution of Escherichia coli to an ?-peptide/?-peptoid peptidomimetic induces stable resistance. PLoS One 2013; 8:e73620.